Brexit
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

US Pharma Firms Not In Post-Brexit Trade Talks

Podcast: Novartis’s $9.7bn Gamble; Higher Drug Prices Post-Brexit? Jefferies Highlights
Join the London-based Eleanor Malone, Andrew McConaghie and Kevin Grogan as they review some of the most eyecatching stories in pharma and healthcare.
Latest From Brexit
Scotland Wants NHS Protected From Post-Brexit Trade Deals
The Scottish National Party has put the NHS, EU membership and Scottish independence at the heart of its campaign as the UK prepares to vote in the 12 December general election.
UK Conservatives Promise ‘Innovative Medicines Fund’ If Re-Elected
More money to pay for innovative new medicines, more cash and support for the life sciences sector, and Brexit by 31 January 2020 are among promises made in the Conservative Party’s election platform.
UK Labour Govt Would Boost Health Spending, Put Pressure On Drug Prices
The election manifesto produced by the Labour Party offers something for everyone, from the dropping of prescription charges and a boost for health care spending to more use of compulsory licensing and the building of a state-owned generics factory to make medicines more affordable.
Latest Notified Body Approval Helps Brexit-Proof EU Medical Devices Regulation
EMA Gets Keys To New HQ And Restarts Some Stalled Activities
The European Medicines Agency has taken possession of its new HQ in Amsterdam and has hired 77 new staff members to make up for the severe staff losses it has witnessed on account of Brexit.
Pharma Declares Wishlist As Brexit Heightens UK Election Stakes
The UK pharma industry association has underscored the sector’s importance while outlining its demands for the country’s policy around medicines and R&D.
UK BIA Targets Next Government With ‘Biotech Manifesto’
The BioIndustry Association has laid out its wishlist for the next UK administration, including deep regulatory alignment with the EU after Brexit, a more “flexible” approach to health technology assessment appraisals of new drugs, and support for R&D.
UK Industry Hit By Brexit Uncertainty, Spies Opportunity
BSI Netherlands Designated Against EU MDR In Vital Move That Should Brexit-Proof Clients
BSI Netherlands is the seventh notified body to be designated under the EU’s Medical Device Regulation. But this latest announcement is one of the most important yet.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.